Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Gonadorelin: Evidence Summary
Evidence summary for Gonadorelin across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to Gonadorelin overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Pituitary diagnostic testing | Tier A | 50 | FDA-approved 1982; gold standard for gonadotroph function assessment |
| Hypogonadotropic hypogonadism | Tier A | 30 | 80% response rate in Phase 3 trials; FDA-approved |
| IVF protocols | Tier A | 100 | Standard of care with multiple meta-analyses |
| Fertility preservation on TRT | Tier B | 10 | Moderate evidence; widely used off-label |